论文信息 - Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk? - 字舞流文

Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?

R. Abbate | M. Salvadori | R. Marcucci | S. Fedi | G. Rosso | E. Bertoni | S. Farsetti | A. Cellai | L. Caroti | M. Zanazzi | A. Rogolino | A. Larti

[1] R. Abbate,et al. Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients , 2003, Transplantation.

[2] R. Abbate,et al. HIGH CYSTEINE LEVELS IN RENAL TRANSPLANT RECIPIENTS: Relationship with Hyperhomocysteinemia and 5,10 -MTHFR Polymorphism , 2001, Transplantation.

[3] B. Kasiske,et al. Cardiovascular disease after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.

[4] I. Rosenberg,et al. Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients. , 1999, Transplantation.

[5] R. Gibey,et al. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. , 2000, Journal of the American Society of Nephrology : JASN.